Mimedx Group, Inc.
MDXG- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001376339
No open-market purchases or sales by Mimedx Group, Inc. insiders were filed in the last 90 days; 227 institutions reported holding it in 13F filings for Q2 2026, worth $430.8M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Mimedx Group, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Mimedx Group, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Doug Rice | Chief Financial Officer | 399,566 | Jul 7, 2026 | 3 |
| Maersk-Moller Kimberly | Chief Commercial Officer | 309,630 | Jun 25, 2026 | 5 |
| Hawkins William A | Director | 254,931 | Jun 12, 2026 | 1 |
| Bierman James L | Director | 263,684 | Jun 12, 2026 | 1 |
| Puhy Dorothy E | Director | 108,510 | Jun 12, 2026 | 1 |
| Olson Tiffany | Director | 108,510 | Jun 12, 2026 | 1 |
| Newton Todd | Director | 463,684 | Jun 12, 2026 | 1 |
| Hulse William Frank IV | General Counsel and CAO | 543,195 | Mar 17, 2026 | 3 |
| Capper Joseph H | Chief Executive Officer | 904,656 | Mar 6, 2026 | 1 |
| Whitlow Ricci S | Chief Operating Officer | 462,825 | Mar 6, 2026 | 2 |
| Behrens M Kathleen | Director | 212,771 | Jun 23, 2025 | 0 |
| Laurencin Cato T | Director | 181,923 | Jun 23, 2025 | 0 |
| Falcon Fund 2 Holding Company, L.P. | 10% Owner | 28,195,249 | Dec 27, 2023 | 0 |
| Gardner Phyllis | Director | 117,024 | Jun 15, 2023 | 0 |
| Giuliani Michael J | Director | 130,124 | Jun 15, 2023 | 0 |
| Stein Robert Benjamin | President, Regenerative Med. | 317,803 | May 17, 2023 | 0 |
| Carlson Peter M | Chief Financial Officer | 656,435 | May 12, 2023 | 0 |
| Phelan William Lawrence | Chief Accounting Officer | 184,219 | May 12, 2023 | 0 |
| Kashyap Rohit | President, WC & Surgical | 430,072 | Aug 11, 2022 | 0 |
| Wright Timothy R | Chief Executive Officer | 1,711,324 | Jun 13, 2022 | 0 |
| Graves Mark | SVP & Chief Compliance Officer | 133,608 | May 10, 2022 | 0 |
| Turner Scott M | SVP, Operations & Procurement | 226,643 | May 4, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Stein Robert BenjaminEVP, Research and Development | SSale | −9.36K | $11.85 | −$110.9K | −4.9%181.7K after | |
| Feb 25, 2022 (view filing) | Feb 23 | 2 days | Wright Timothy RChief Executive Officer | SSale | −61.0K | $4.31 | −$262.9K | −4.6%1.27M after | |
| Feb 25, 2022 (view filing) | Feb 23 | 2 days | Turner Scott MSVP, Operations & Procurement | SSale | −5.74K | $4.50 | −$25.8K | −3.2%174.6K after | |
| Feb 25, 2022 (view filing) | Feb 23 | 2 days | Hulse William Frank IVGeneral Counsel | SSale | −13.5K | $4.41 | −$59.5K | −6.4%196.3K after | |
| Feb 28, 2022 (view filing) | Feb 24 | 4 days | Graves MarkSVP & Chief Compliance Officer | SSale | −4.53K | $4.32 | −$19.5K | −4.7%92.2K after | |
| Mar 1, 2022 (view filing) | Feb 25 | 4 days | Carlson Peter MChief Financial Officer | SSale | −17.4K | $4.83 | −$84.0K | −4.2%393.4K after | |
| Mar 10, 2022 (view filing) | Mar 8 | 2 days | Phelan William LawrenceChief Accounting Officer | SSale | −3.27K | $4.86 | −$15.9K | −3.2%97.4K after | |
| Mar 10, 2022 (view filing) | Mar 8 | 2 days | Stein Robert BenjaminEVP, Research and Development | SSale | −11.7K | $4.86 | −$56.7K | −6.4%170.0K after | |
| Mar 10, 2022 (view filing) | Mar 8 | 2 days | Hulse William Frank IVGeneral Counsel | SSale | −9.99K | $4.86 | −$48.6K | −5.1%186.3K after | |
| Mar 10, 2022 (view filing) | Mar 8 | 2 days | Carlson Peter MChief Financial Officer | SSale | −10.7K | $4.86 | −$52.2K | −2.7%382.7K after | |
| Mar 10, 2022 (view filing) | Mar 8 | 2 days | Graves MarkSVP & Chief Compliance Officer | SSale | −3.23K | $4.86 | −$15.7K | −3.5%89.0K after | |
| Mar 10, 2022 (view filing) | Mar 8 | 2 days | Kashyap RohitEVP & Chief Commercial Officer | SSale | −8.77K | $4.86 | −$42.6K | −3.2%263.8K after | |
| Mar 10, 2022 (view filing) | Mar 8 | 2 days | Turner Scott MSVP, Operations & Procurement | SSale | −4.16K | $4.86 | −$20.2K | −2.4%170.4K after | |
| Mar 10, 2022 (view filing) | Mar 8 | 2 days | Wright Timothy RChief Executive Officer | SSale | −45.6K | $4.86 | −$221.7K | −3.6%1.22M after | |
| May 4, 2022 (view filing) | May 2 | 2 days | Turner Scott MSVP, Operations & Procurement | SSale | −5.26K | $4.00 | −$21.0K | −2.3%226.6K after | |
| May 10, 2022 (view filing) | May 6 | 4 days | Phelan William LawrenceChief Accounting Officer | SSale | −5.75K | $3.81 | −$21.9K | −3.8%144.6K after | |
| May 10, 2022 (view filing) | May 9 | 1 day | Graves MarkSVP & Chief Compliance Officer | SSale | −3.89K | $3.50 | −$13.6K | −2.8%133.6K after | |
| Jun 13, 2022 (view filing) | Jun 9 | 4 days | Wright Timothy RChief Executive Officer | SSale | −112.0K | $3.75 | −$420.0K | −6.1%1.71M after | |
| Jun 30, 2022 (view filing) | Jun 28 | 2 days | Stein Robert BenjaminPresident, Regenerative Med. | SSale | −14.6K | $3.47 | −$50.7K | −4.2%334.0K after | |
| Aug 8, 2022 (view filing) | Aug 4 | 4 days | Stein Robert BenjaminPresident, Regenerative Med. | SSale | −19.5K | $3.62 | −$70.6K | −5.8%314.5K after | |
| Aug 11, 2022 (view filing) | Aug 9 | 2 days | Kashyap RohitPresident, WC & Surgical | SSale | −12.3K | $4.21 | −$52.0K | −2.8%430.1K after | |
| Aug 16, 2022 (view filing) | Aug 12 | 4 days | Stein Robert BenjaminPresident, Regenerative Med. | SSale | −8.50K | $4.04 | −$34.4K | −2.7%306.0K after | |
| Sep 14, 2022 (view filing) | Sep 12-13 | 2 days | Stein Robert BenjaminPresident, Regenerative Med. | SSale | −27.3K | $3.45 | −$94.2K | −8.9%278.7K after | 2 lots |
| Dec 27, 2022 (view filing) | Dec 22 | 5 days | Carlson Peter MChief Financial Officer | SSale | −4.99K | $2.82 | −$14.1K | −0.9%565.2K after | |
| Feb 24, 2023 (view filing) | Feb 23 | 1 day | Carlson Peter MChief Financial Officer | SSale | −19.0K | $4.50 | −$85.5K | −3.4%546.2K after | |
| Feb 24, 2023 (view filing) | Feb 23 | 1 day | Hulse William Frank IVGeneral Counsel and CAO | SSale | −15.6K | $4.53 | −$70.5K | −4.3%349.4K after | |
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Phelan William LawrenceChief Accounting Officer | SSale | −3.40K | $4.24 | −$14.4K | −2.3%141.2K after | |
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Stein Robert BenjaminPresident, Regenerative Med. | SSale | −12.4K | $4.24 | −$52.4K | −4.4%266.3K after | |
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Carlson Peter MChief Financial Officer | SSale | −12.1K | $4.24 | −$51.1K | −2.2%534.1K after | |
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Hulse William Frank IVGeneral Counsel and CAO | SSale | −11.3K | $4.24 | −$47.9K | −3.2%338.1K after | |
| Apr 13, 2023 (view filing) | Apr 11 | 2 days | Carlson Peter MChief Financial Officer | SSale | −6.10K | $3.31 | −$20.2K | −0.9%668.5K after | |
| Apr 13, 2023 (view filing) | Apr 11 | 2 days | Stein Robert BenjaminPresident, Regenerative Med. | SSale | −6.00K | $3.31 | −$19.8K | −1.5%395.4K after | |
| Apr 13, 2023 (view filing) | Apr 11 | 2 days | Phelan William LawrenceChief Accounting Officer | SSale | −1.63K | $3.31 | −$5.40K | −0.8%192.6K after | |
| Apr 13, 2023 (view filing) | Apr 11 | 2 days | Hulse William Frank IVGeneral Counsel and CAO | SSale | −6.00K | $3.31 | −$19.8K | −1.3%468.4K after | |
| Apr 27, 2023 (view filing) | Apr 25 | 2 days | Carlson Peter MChief Financial Officer | SSale | −6.09K | $3.74 | −$22.8K | −0.9%662.4K after | |
| Apr 27, 2023 (view filing) | Apr 25 | 2 days | Stein Robert BenjaminPresident, Regenerative Med. | SSale | −5.99K | $3.74 | −$22.4K | −1.5%389.4K after | |
| Apr 27, 2023 (view filing) | Apr 25 | 2 days | Phelan William LawrenceChief Accounting Officer | SSale | −1.63K | $3.74 | −$6.09K | −0.8%191.0K after | |
| Apr 27, 2023 (view filing) | Apr 25 | 2 days | Hulse William Frank IVGeneral Counsel and CAO | SSale | −5.99K | $3.74 | −$22.4K | −1.3%462.4K after | |
| May 3, 2023 (view filing) | May 2 | 1 day | Phelan William LawrenceChief Accounting Officer | SSale | −5.20K | $3.80 | −$19.8K | −2.7%185.8K after | |
| May 9, 2023 (view filing) | May 4 | 5 daysLate | Stein Robert BenjaminPresident, Regenerative Med. | SSale | −51.8K | $5.34 | −$276.4K | −13.3%337.6K after | |
| May 12, 2023 (view filing) | May 10 | 2 days | Carlson Peter MChief Financial Officer | SSale | −5.98K | $5.93 | −$35.4K | −0.9%656.4K after | |
| May 12, 2023 (view filing) | May 10 | 2 days | Phelan William LawrenceChief Accounting Officer | SSale | −1.59K | $5.93 | −$9.46K | −0.9%184.2K after | |
| May 12, 2023 (view filing) | May 10 | 2 days | Stein Robert BenjaminPresident, Regenerative Med. | SSale | −5.87K | $5.93 | −$34.8K | −1.7%331.8K after | |
| May 12, 2023 (view filing) | May 10 | 2 days | Hulse William Frank IVGeneral Counsel and CAO | SSale | −5.87K | $5.93 | −$34.8K | −1.3%456.6K after | |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Stein Robert BenjaminPresident, Regenerative Med. | SSale | −14.0K | $6.00 | −$83.9K | −4.2%317.8K after | 2 lots |
| Jun 26, 2023 (view filing) | Jun 22-23 | 4 days | Capper Joseph HChief Executive Officer | PPurchase | +100.0K | $6.40 | +$640.1K | New position100.0K after | 2 lots |
| Nov 22, 2023 (view filing) | Nov 21 | 1 day | Doug RiceChief Financial Officer | PPurchase | +5.00K | $7.16 | +$35.8K | +5.1%102.2K after | |
| Feb 16, 2024 (view filing) | Feb 14-15 | 2 days | Whitlow Ricci SChief Operating Officer | SSale | −31.0K | $8.04 | −$249.7K | −6.7%431.8K after | 2 lots |
| Feb 21, 2024 (view filing) | Feb 16-20 | 5 days | Whitlow Ricci SChief Operating Officer | SSale | −30.8K | $8.04 | −$247.3K | −7.1%401.1K after | 2 lots |
| Mar 15, 2024 (view filing) | Mar 13 | 2 days | Hulse William Frank IVGeneral Counsel and CAO | SSale | −20.4K | $7.95 | −$162.0K | −4.1%480.0K after |